One of the most common questions from users is, Where to inject Wegovy for maximum effectiveness and minimal discomfort
The lawsuit argues that Novo Nordisk failed to warn users about the risk of NAION
While the weight loss is moderate compared to newer agents, the tolerability profile is genuinely superior for many individuals
Factors that influence early weight loss include starting body weight, baseline diet quality, physical activity level, hydration status, and individual metabolic rate
The most common side effect is mild, temporary weight gain, but you can reduce that risk by skipping the high-dose loading period and sticking to a 3 to 5 g daily dose instead
No one should have to compromise their health due to misinformation and reach for fake or illegitimate knockoff drugs that pose significant safety risks to patients, Novo Nordisk said in a statement when the FDA declared the end of the semaglutide shortage